- 专利标题: Lanthanide complex formulations
-
申请号: US17851454申请日: 2022-06-28
-
公开(公告)号: US12070511B2公开(公告)日: 2024-08-27
- 发明人: Mikkel Jacob Thaning , Andreas Richard Meijer
- 申请人: GE HEALTHCARE AS
- 申请人地址: NO Oslo
- 专利权人: GE HEALTHCARE AS
- 当前专利权人: GE HEALTHCARE AS
- 当前专利权人地址: NO Oslo
- 代理机构: MCANDREWS HELD & MALLOY, LTD
- 优先权: GB 21162 2014.11.28
- 分案原申请号: US16752307 2020.01.24
- 主分类号: A61K49/10
- IPC分类号: A61K49/10 ; A61K9/00 ; A61K31/28 ; C07D257/00
摘要:
The present invention relates to a method of removal of metal ion impurities, such as calcium, from lanthanide metal complexes of macrocyclic chelators. The method uses a scavenger resin to remove metal ions, displaced from chelator, by an excess of lanthanide ions. Also provided is a method of preparation of MRI contrast agents, from the purified lanthanide metal complex, by the addition of a defined excess chelator.
公开/授权文献
- US20220354971A1 LANTHANIDE COMPLEX FORMULATIONS 公开/授权日:2022-11-10
信息查询